XML 70 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Original and Further Restatement of the Consolidated Financial Statements (Tables)
12 Months Ended
Dec. 31, 2013
Text Block [Abstract]  
Effects of Original Restatement and Further Restatement to Previously Filed Consolidated Income Statements

The tables below show the effects of the Original Restatement for each of the fiscal years ended December 31, 2012 and 2011, as well as the effects of the Further Restatement for each of the fiscal years ended December 31, 2013, 2012 and 2011. In each case, the tax effect of the adjustments is estimated based on the Company’s estimated tax rate.

 

     Year Ended December 31, 2013  
           Further Restatement Adjustments by Category        
(U.S. Dollars, in thousands)    Originally
Reported
    Co-Pay and
Self-Pay
Revenue
    Bad Debt
Timing
    Accounts
Receivable
Reserve
    Intercompany
Profit
    Inventory     Other     Total Further
Restatement
Adjustments
    Restated  

Net sales

   $ 400,534      $ (2,242   $ —        $ (582   $ —        $ —        $ (99   $ (2,923   $ 397,611   

Cost of sales

     102,300        —          —          —          1,090        3,688        (166     4,612        106,912   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  298,234      (2,242   —        (582   (1,090   (3,688   67      (7,535   290,699   

Operating expenses

Sales and marketing

  176,581      (2,242   1,455      122      —        —        (448   (1,113   175,468   

General and administrative

  65,147      —        —        —        —        —        (317   (317   64,830   

Research and development

  26,768      —        —        —        —        —        —        —        26,768   

Amortization of intangible assets

  2,687      —        —        —        —        —        —        —        2,687   

Costs related to the accounting review and restatement

  12,945      —        —        —        —        —        —        —        12,945   

Impairment of Goodwill

  19,193      —        —        —        —        —        —        —        19,193   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  303,321      (2,242   1,455      122      —        —        (765   (1,430   301,891   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating (loss) income

  (5,087   —        (1,455   (704   (1,090   (3,688   832      (6,105   (11,192

Other income and (expense)

  295      —        —        —        —        —        294      294      589   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

  (4,792   —        (1,455   (704   (1,090   (3,688   1,126      (5,811   (10,603

Income tax expense

  (10,116   —        509      246      381      1,290      88      2,514      (7,602
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

$ (14,908 $ —      $ (946 $ (458 $ (709 $ (2,398 $ 1,214    $ (3,297 $ (18,205
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Year Ended December 31, 2012  
           Original Restatement Adjustments by Category        
(U.S. Dollars, in thousands)    As Reported
in the 2012
Form 10-K
Prior to
Original
Restatement
    Distributor
Revenue
    Inventory
Reserves
    Royalties     Other     Total Original
Restatement
Adjustments
    As Originally
Restated in
2012

Form 10-K/A
 

Net sales

   $ 462,320      $ (14,777   $ —        $ —        $ 38      $ (14,739   $ 447,581   

Cost of sales

     86,492        (2,032     5,647        8,190        (44     11,761        98,253   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  375,828      (12,745   (5,647   (8,190   82      (26,500   349,328   

Operating expenses

Sales and marketing

  200,343      (6,629   —        (8,190   1,607      (13,212   187,131   

General and administrative

  53,827      (2   —        —        (434   (436   53,391   

Research and development

  28,577      —        —        —        —        —        28,577   

Amortization of intangible assets

  2,098      —        —        —        200      200      2,298   

Charges related to U.S. Government resolutions

  1,973      —        —        —        (678   (678   1,295   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  286,818      (6,631   —        (8,190   695      (14,126   272,692   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  89,010      (6,114   (5,647   —        (613   (12,374   76,636   

Other income and (expense)

  (6,282   —        —        —        (166   (166   (6,448
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

  82,728      (6,114   (5,647   —        (779   (12,540   70,188   

Income tax expense

  (28,792   1,782      1,645      —        227      3,654      (25,138
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

$ 53,936    $ (4,332 $ (4,002 $  —      $ (552 $ (8,886 $ 45,050   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Year Ended December 31, 2012  
           Further Restatement Adjustments by Category        
(U.S. Dollars, in thousands)    As Originally
Restated in
2012

Form 10-K/A
    Co-Pay and
Self-Pay
Revenue
    Bad Debt
Timing
    Accounts
Receivable
Reserve
    Intercompany
Profit
    Inventory     Other     Total Further
Restatement
Adjustments
    Restated  

Net sales

   $ 447,581      $ (9,049   $ —        $ 1,653      $ —        $ —        $ 4      $ (7,392   $ 440,189   

Cost of sales

     98,253        —          —          —          207        1,774        492        2,473        100,726   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  349,328      (9,049   —        1,653      (207   (1,774   (488 $ (9,865   339,463   

Operating expenses

Sales and marketing

  187,131      (9,049   1,097      (408   —        —        —      $ (8,360   178,771   

General and administrative

  53,391      —        —        —        —        —        259      259      53,650   

Research and development

  28,577      —        —        —        —        —        —        —        28,577   

Amortization of intangible assets

  2,298      —        —        —        —        —        —        —        2,298   

Charges related to U.S. Government resolutions

  1,295      —        —        —        —        —        —        —        1,295   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  272,692      (9,049   1,097      (408   —        —        259      (8,101   264,591   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  76,636      —        (1,097   2,061      (207   (1,774   (747   (1,764   74,872   

Other income and (expense)

  (6,448   —        —        —        —        —        641      641    $ (5,807
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

  70,188      —        (1,097   2,061      (207   (1,774   (106   (1,123   69,065   

Income tax expense

  (25,138   —        384      (721   72      621      838      1,194    $ (23,944
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

$ 45,050    $  —      $ (713 $ 1,340    $ (135 $ (1,153 $ 732    $ 71    $ 45,121   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

     Year Ended December 31, 2011  
           Original Restatement Adjustments by Category        
(U.S. Dollars, in thousands)    As Reported
in the 2012
Form 10-K
Prior to
Original
Restatement
    Distributor
Revenue
    Inventory
Reserves
    Royalties     Other     Total Original
Restatement
Adjustments
    As Originally
Restated in
2012

Form 10-K/A
 

Net sales

   $ 470,121      $ (29,135   $ —        $  —        $ 985      $ (28,150   $ 441,971   

Cost of sales

     92,619        (8,289     3,377        7,713        107        2,908        95,527   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  377,502      (20,846   (3,377   (7,713   878      (31,058   346,444   

Operating expenses

Sales and marketing

  200,145      (1,216   —        (7,713   2,295      (6,634   193,511   

General and administrative

  64,374      —        —        —        107      107      64,481   

Research and development

  22,861      —        —        —        —        —        22,861   

Amortization of intangible assets

  2,350      —        —        —        200      200      2,550   

Charges related to U.S. Government resolutions

  56,463      —        —        —        678      678      57,141   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  346,193      (1,216   —        (7,713   3,280      (5,649   340,544   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  31,309      (19,630   (3,377   —        (2,402   (25,409   5,900   

Other income and (expense)

  (11,868   —        —        —        3,915      3,915      (7,953
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

  19,441      (19,630   (3,377   —        1,513      (21,494   (2,053

Income tax expense

  (21,181   6,408      1,102      —        (494   7,016      (14,165
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

$ (1,740 $ (13,222 $ (2,275 $ —      $ 1,019    $ (14,478 $ (16,218
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

    Year Ended December 31, 2011  
          Further Restatement Adjustments by Category        
(U.S. Dollars, in thousands)   As Originally
Restated in
2012
Form 10-K/A
    Co-Pay and
Self-Pay
Revenue
    Bad Debt
Timing
    Accounts
Receivable
Reserve
    Intercompany
Profit
    Inventory     Other     Total Further
Restatement
Adjustments
    Restated  

Net sales

  $ 441,971      $ (5,960   $ —       $ (439 )   $ —       $ —       $ (53   $ (6,452   $ 435,519   

Cost of sales

    95,527        —         —         —         253        321        314        888        96,415   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  346,444      (5,960   —       (439 )   (253   (321   (367   (7,340   339,104   

Operating expenses

Sales and marketing

  193,511      (5,960   (2,143   (252 )   —       —       —       (8,355   185,156   

General and administrative

  64,481      —       —       —       —       —       304      304      64,785   

Research and development

  22,861      —       —       —       —       —       —       —       22,861   

Amortization of intangible assets

  2,550      —       —       —       —       —       —       —       2,550   

Charges related to U.S. Government resolutions

  57,141      —       —       —       —       —       —       —       57,141   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  340,544      (5,960   (2,143   (252   —       —       304      (8,051   332,493   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  5,900      —       2,143      (187 )   (253   (321   (671   711      6,611   

Other income and (expense)

  (7,953   —       —       —       —       —       (21   (21   (7,974
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

  (2,053   —       2,143      (187 )   (253   (321   (692   690      (1,363

Income tax expense

  (14,165   —       (752   66      89      113      206      (278   (14,443
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

$ (16,218 $ —     $ 1,391    $ (121 ) $ (164 $ (208 $ (486 $ 412    $ (15,806
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

Effects of Original Restatement and Further Restatement on Consolidated Balance Sheet

The effects of the Further Restatement on the Company’s consolidated balance sheet as of December 31, 2013 are as follows:

 

     As of December 31, 2013  

(U.S. Dollars, in thousands except share and per share data)

   Originally
Reported in
2013

Form 10-K
     Further
Restatement
Adjustments
    Restated  

Assets

       

Current assets:

       

Cash and cash equivalents

   $ 30,486       $ (1,562   $ 28,924   

Restricted cash

     23,761         —          23,761   

Trade accounts receivable, less allowances of $9,111

     75,567         (4,756     70,811   

Inventories

     90,577         (17,899     72,678   

Deferred income taxes

     33,947         6,052        39,999   

Prepaid expenses and other current assets

     25,906         3,027        28,933   
  

 

 

    

 

 

   

 

 

 

Total current assets

  280,244      (15,138   265,106   

Property, plant and equipment, net

  54,606      (234   54,372   

Patents and other intangible assets, net

  9,046      —        9,046   

Goodwill

  53,565      —        53,565   

Deferred income taxes

  18,336      4,058      22,394   

Other long-term assets

  7,385      107      7,492   
  

 

 

    

 

 

   

 

 

 

Total assets

$ 423,182    $ (11,207 $ 411,975   
  

 

 

    

 

 

   

 

 

 

Liabilities and shareholders’ equity

Current liabilities:

Trade accounts payable

$ 20,674    $ —      $ 20,674   

Other current liabilities

  46,146      3,530      49,676   
  

 

 

    

 

 

   

 

 

 

Total current liabilities

  66,820      3,530      70,350   

Long-term debt

  20,000      —        20,000   

Deferred income taxes

  13,132      (106   13,026   

Other long-term liabilities

  12,736      —        12,736   
  

 

 

    

 

 

   

 

 

 

Total liabilities

  112,688      3,424      116,112   

Contingencies (Note 17)

Shareholders’ equity

Common shares $0.10 par value; 50,000,000 shares authorized; 18,102,335 issued and outstanding

  1,810      —        1,810   

Additional paid-in capital

  216,653      —        216,653   

Retained earnings

  89,332      (15,435   73,897   

Accumulated other comprehensive income

  2,699      804      3,503   
  

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

  310,494      (14,631   295,863   
  

 

 

    

 

 

   

 

 

 

Total liabilities and shareholders’ equity

$ 423,182    $ (11,207 $ 411,975   
  

 

 

    

 

 

   

 

 

 

 

The effects of the Original Restatement and the Further Restatement on the Company’s consolidated balance sheet as of December 31, 2012 are as follows:

 

     As of December 31, 2012  

(U.S. Dollars, in thousands except share and per share data)

   As Reported in
the 2012 Form
10-K Prior to
Original
Restatement
     Original
Restatement
Adjustments
    As Originally
Restated in the
2012

Form 10-K/A
     Further
Restatement
Adjustments
    Restated  

Assets

       

Current assets:

       

Cash and cash equivalents

   $ 31,055       $ —        $ 31,055       $ (288   $ 30,767   

Restricted cash

     21,314         —          21,314         —          21,314   

Trade accounts receivable, less allowances of $6,673

     150,316         (43,004     107,312         (3,510     103,802   

Inventories

     88,744         (5,371     83,373         (13,560     69,813   

Deferred income taxes

     16,959         16,491        33,450         5,037        38,487   

Prepaid expenses and other current assets

     32,056         2,023        34,079         2,370        36,449   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total current assets

  340,444      (29,861   310,583      (9,951   300,632   

Property, plant and equipment, net

  51,362      2,473      53,835      (1,042   52,793   

Patents and other intangible assets, net

  6,880      410      7,290      —        7,290   

Goodwill

  74,388      —        74,388      —        74,388   

Deferred income taxes

  19,904      (1,023   18,881      2,642      21,523   

Other long-term assets

  11,303      (3,383   7,920      —        7,920   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total assets

$ 504,281    $ (31,384 $ 472,897    $ (8,351 $ 464,546   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Liabilities and shareholders’ equity

Current liabilities:

Bank borrowings

$ 16    $ —      $ 16    $ —      $ 16   

Trade accounts payable

  21,812      763      22,575      —        22,575   

Other current liabilities

  46,969      (7,375   39,594      3,148      42,742   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total current liabilities

  68,797      (6,612   62,185      3,148      65,333   

Long-term debt

  20,000      —        20,000      —        20,000   

Deferred income taxes

  11,456      —        11,456      (106   11,350   

Other long-term liabilities

  4,930      6,494      11,424      —        11,424   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total liabilities

  105,183      (118   105,065      3,042      108,107   

Contingencies (Note 17)

Shareholders’ equity

Common shares $0.10 par value; 50,000,000 shares authorized; 19,339,329 issued and outstanding

  1,934      —        1,934      —        1,934   

Additional paid-in capital

  246,111      195      246,306      —        246,306   

Retained earnings

  148,549      (33,702   114,847      (12,138   102,709   

Accumulated other comprehensive income

  2,504      2,241      4,745      745      5,490   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total shareholders’ equity

  399,098      (31,266   367,832      (11,393   356,439   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 

Total liabilities and shareholders’ equity

$ 504,281    $ (31,384 $ 472,897    $ (8,351 $ 464,546   
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

 
Effects of Original Restatement and Further Restatement of Consolidated Statement of Operations and Comprehensive Income (Loss)

The effects of the Further Restatement on the Company’s consolidated statement of operations and comprehensive income for the year ended December 31, 2013 are as follows:

 

     Year Ended December 31, 2013  
(U.S. Dollars, in thousands, except share and per share data)    Originally
Reported in 2013

Form 10-K
    Further
Restatement
Adjustments
    Restated  

Product sales

   $ 352,796      $ (3,244   $ 349,552   

Marketing service fees

     47,738        321        48,059   
  

 

 

   

 

 

   

 

 

 

Net sales

  400,534      (2,923   397,611   

Cost of sales

  102,300      4,612      106,912   
  

 

 

   

 

 

   

 

 

 

Gross profit

  298,234      (7,535   290,699   

Operating expenses

Sales and marketing

  176,581      (1,113   175,468   

General and administrative

  65,147      (317   64,830   

Research and development

  26,768      —       26,768   

Amortization of intangible assets

  2,687      —       2,687   

Costs related to the accounting review and restatement

  12,945      —       12,945   

Impairment of Goodwill

  19,193      —       19,193   
  

 

 

   

 

 

   

 

 

 
  303,321      (1,430   301,891   
  

 

 

   

 

 

   

 

 

 

Operating loss

  (5,087   (6,105   (11,192

Other income and (expense)

Interest expense, net

  (1,925   98      (1,827

Other expense

  2,220      196      2,416   
  

 

 

   

 

 

   

 

 

 
  295      294      589   
  

 

 

   

 

 

   

 

 

 

Loss before income taxes

  (4,792   (5,811   (10,603

Income tax expense

  (10,116   2,514      (7,602
  

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

  (14,908   (3,297   (18,205
  

 

 

   

 

 

   

 

 

 

Discontinued operations (Note 16)

Loss from discontinued operations

  (15,510   —        (15,510

Income tax benefit (expense)

  4,903      —        4,903   
  

 

 

   

 

 

   

 

 

 

Net loss from discontinued operations

  (10,607   —        (10,607
  

 

 

   

 

 

   

 

 

 

Net loss

$ (25,515 $ (3,297 $ (28,812
  

 

 

   

 

 

   

 

 

 

Net loss per common share—basic:

Net loss from continuing operations

$ (0.80 $ (0.17 $ (0.97

Net loss from discontinued operations

  (0.57   —       (0.57
  

 

 

   

 

 

   

 

 

 

Net loss per common share—basic

$ (1.37 $ (0.17 $ (1.54
  

 

 

   

 

 

   

 

 

 

Net loss per common share—diluted:

Net loss from continuing operations

$ (0.80 $ (0.17 $ (0.97

Net loss from discontinued operations

  (0.57   —       (0.57
  

 

 

   

 

 

   

 

 

 

Net loss per common share—diluted

$ (1.37 $ (0.17 $ (1.54
  

 

 

   

 

 

   

 

 

 

Weighted average number of common shares:

Basic

  18,697,228      —       18,697,228   

Diluted

  18,697,228      —       18,697,228   

Other comprehensive loss, before tax:

Translation adjustment

$ (1,768 $ 60    $ (1,708

Unrealized gain on derivative instrument

  (442   (1 )   (443
  

 

 

   

 

 

   

 

 

 

Other comprehensive loss, before tax

  (2,210   59      (2,151

Income tax expense related to components of other comprehensive income

  164      —       164   
  

 

 

   

 

 

   

 

 

 

Other comprehensive loss, net of tax

  (2,046   59      (1,987
  

 

 

   

 

 

   

 

 

 

Comprehensive loss

$ (27,561 $ (3,238 $ (30,799
  

 

 

   

 

 

   

 

 

 

 

The effects of the Original Restatement and the Further Restatement on the Company’s consolidated statement of operations and comprehensive income for the year ended December 31, 2012 are as follows:

 

     Year Ended December 31, 2012  
(U.S. Dollars, in thousands, except share and per share data)    As Reported in the
2012 Form 10-K
Prior to Original
Restatement
    Original
Restatement
Adjustments
    As Originally
Restated in the
2012

Form 10-K/A
    Further
Restatement
Adjustments
    Restated  

Product sales

   $ 415,850      $ (14,811   $ 401,039      $ (7,392   $ 393,647   

Marketing service fees

     46,470        72        46,542        —          46,542   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

  462,320      (14,739   447,581      (7,392   440,189   

Cost of sales

  86,492      11,761      98,253      2,473      100,726   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  375,828      (26,500   349,328      (9,865   339,463   

Operating expenses

Sales and marketing

  200,343      (13,212   187,131      (8,360   178,771   

General and administrative

  53,827      (436   53,391      259      53,650   

Research and development

  28,577      —        28,577      —        28,577   

Amortization of intangible assets

  2,098      200      2,298      —        2,298   

Charges related to U.S. Government resolutions (Note 17)

  1,973      (678   1,295      —        1,295   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  286,818      (14,126   272,692      (8,101   264,591   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  89,010      (12,374   76,636      (1,764   74,872   

Other income and (expense)

Interest expense, net

  (4,577   (166   (4,743   582      (4,161

Other expense

  (1,705   —       (1,705   59      (1,646
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (6,282   (166   (6,448   641      (5,807
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

  82,728      (12,540   70,188      (1,123   69,065   

Income tax expense

  (28,792   3,654      (25,138   1,194      (23,944
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

  53,936      (8,886   45,050      71      45,121   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Discontinued operations (Note 16)

Gain on sale of Breg, Inc.,

  1,345      —        1,345      —        1,345   

Loss from discontinued operations

  (4,012   1,018      (2,994   (500   (3,494

Income tax benefit (expense)

  26      (589   (563   443      (120 )  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from discontinued operations

  (2,641   429      (2,212   (57   (2,269
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income

$ 51,295    $ (8,457 $ 42,838    $ 14    $ 42,852   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per common share—basic:

Net income from continuing operations

$ 2.84    $ (0.47 $ 2.37    $ 0.01    $ 2.38   

Net loss from discontinued operations

  (0.14   0.02      (0.12   —        (0.12
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per common share—basic

$ 2.70    $ (0.45 $ 2.25    $ 0.01    $ 2.26   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) per common share—diluted:

Net income from continuing operations

$ 2.78    $ (0.46 $ 2.32    $ 0.01    $ 2.33   

Net loss from discontinued operations

  (0.14   0.03      (0.11   (0.01   (0.12
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income per common share—diluted:

$ 2.64    $ (0.43 $ 2.21    $ 0.00    $ 2.21   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares:

Basic

  18,977,263      —        18,977,263      —        18,977,263   

Diluted

  19,390,413      —        19,390,413      —        19,390,413   

Other comprehensive income, before tax:

Translation adjustment

$ 480    $ 288    $ 768    $ 363    $ 1,131   

Unrealized gain on derivative instrument

  416      —        416      —        416   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income, before tax

  896      288      1,184      363      1,547   

Income tax expense related to components of other comprehensive income

  (153   —        (153   —        (153
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income, net of tax

  743      288      1,031      363      1,394   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income

$ 52,038    $ (8,169 $ 43,869    $ 377    $ 44,246   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

The effects of the Original Restatement and the Further Restatement on the Company’s consolidated statement of operations and comprehensive loss for the year ended December 31, 2011 are as follows:

 

     Year Ended December 31, 2011  
(U.S. Dollars, in thousands, except share and per share data)    As Reported in the
2012 Form 10-K
Prior to Original
Restatement
    Original
Restatement
Adjustments
    As Originally
Restated in the
2012

Form 10-K/A
    Further
Restatement
Adjustments
    Restated  

Product sales

   $ 432,975      $ (27,828   $ 405,147        (6,452   $ 398,695   

Marketing service fees

     37,146        (322     36,824        —         36,824   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net sales

  470,121      (28,150   441,971      (6,452   435,519   

Cost of sales

  92,619      2,908      95,527      888      96,415   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

  377,502      (31,058   346,444      (7,340   339,104   

Operating expenses

Sales and marketing

  200,145      (6,634   193,511      (8,355   185,156   

General and administrative

  64,374      107      64,481      304      64,785   

Research and development

  22,861      —        22,861      —       22,861   

Amortization of intangible assets

  2,350      200      2,550      —       2,550   

Charges related to U.S. Government resolutions (Note 17)

  56,463      678      57,141      —       57,141   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  346,193      (5,649   340,544      (8,051   332,493   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

  31,309      (25,409   5,900      711      6,611   

Other income and (expense)

Interest expense, net

  (9,456   3,915      (5,541   100      (5,441

Other expense

  (2,412   —       (2,412   (121   (2,533
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
  (11,868   3,915      (7,953   (21   (7,974
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

  19,441      (21,494   (2,053   690      (1,363

Income tax expense

  (21,181   7,016      (14,165   (278   (14,443
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss from continuing operations

  (1,740   (14,478   (16,218   412      (15,806
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Discontinued operations (Note 16)

Income (loss) from discontinued operations

  1,263      (3,968   (2,705   —       (2,705

Income tax (expense) benefit

  (596   1,409      813      —       813   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) from discontinued operations

  667      (2,559   (1,892   —       (1,892
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

$ (1,073 $ (17,037 $ (18,110   412    $ (17,698
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income per common share—basic:

Net loss from continuing operations

$ (0.10 $ (0.79 $ (0.89 $ 0.02    $ (0.87

Net income (loss) from discontinued operations

  0.04      (0.14   (0.10   —        (0.10
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share—basic

$ (0.06 $ (0.93 $ (0.99 $ 0.02    $ (0.97
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income per common share—diluted:

Net loss from continuing operations

$ (0.10 $ (0.79 $ (0.89 $ 0.02    $ (0.87

Net income (loss) from discontinued operations

  0.04      (0.14   (0.10   —        (0.10
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per common share—diluted:

$ (0.06 $ (0.93 $ (0.99 $ 0.02    $ (0.97
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares:

Basic

  18,219,343      —        18,219,343      —       18,219,343   

Diluted

  18,219,343      —        18,219,343      —       18,219,343   

Other comprehensive loss, before tax:

Translation adjustment

$ (3,192 $ 913    $ (2,279 $ 382   $ (1,897

Unrealized loss on derivative instrument

  (693   —        (693   —       (693
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive loss, before tax

  (3,885   913      (2,972   382      (2,590

Income tax benefit related to components of other comprehensive income

  256      —        256      —       256   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive loss, net of tax

  (3,629   913      (2,716   382      (2,334
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive loss

$ (4,702 $ (16,124 $ (20,826   794    $ (20,032
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
Effects of Original Restatement and Further Restatement on Consolidated Cash Flow

The effects of Further Restatement on the Company’s consolidated statement of cash flows for the year ended December 31, 2013 are as follows:

 

(U.S. Dollars, in thousands)

   Year Ended December 31, 2013  
     Originally
Reported in
2013

Form 10-K
    Further
Restatement
Adjustments
    Restated  

Cash flows from operating activities:

      

Net loss

   $ (25,515   $ (3,297   $ (28,812

Adjustments to reconcile net loss to net cash provided by operating activities:

      

Depreciation and amortization

     22,659        163        22,822   

Amortization of debt costs

     720        —          720   

Amortization of exclusivity agreements

     1,546        —          1,546   

Provision for doubtful accounts

     6,003        (1,413     4,590   

Deferred income taxes

     (1,986     4,815        2,829   

Share-based compensation

     6,267        —          6,267   

Impairment of goodwill

     19,193        —         19,193   

Gain on sale of Breg, Inc., net of tax

     —         —          —    

Excess income tax benefit on employee stock-based awards

     (82     —          (82

Income tax benefit (expense) on employee stock-based awards

     795        (795     —     

Other

     4,442        94        4,536   

Changes in operating assets and liabilities, net of effect of dispositions:

      

Trade accounts receivable

     25,747        2,815        28,562   

Inventories

     (6,626     3,413        (3,213

Escrow receivable

     —         —          —    

Prepaid expenses and other current assets

     6,791        1,973        8,764   

Trade accounts payable

     (2,280     —          (2,280

Charges related to U.S. Government resolutions

     —         —          —    

Other current liabilities

     8,018        (1,049     6,969   

Other long-term assets

     2,750        (8,079     (5,329

Other long-term liabilities

     (1,561     1,521        (40
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

  66,881      161      67,042   

Cash flows from investing activities:

Capital expenditures for property, plant and equipment

  (24,787   —        (24,787

Capital expenditures for intangible assets

  (4,891   —        (4,891

Purchase of other investments

  —       (1,374   (1,374 )

Net proceeds from sale of Breg, Inc.

  —       —        —    
  

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by investing activities

  (29,678   (1,374   (31,052

Cash flows from financing activities:

Net proceeds from issuance of common shares

  3,450      —        3,450   

Payment of refinancing fees and debt issuance costs

  —       —        —    

Repayments of long-term debt

  (16   —        (16

Repayment of bank borrowings, net

  —       —        —    

Changes in restricted cash

  (2,375   —        (2,375

Purchase of common stock

  (39,494   —        (39,494

Cash payment for purchase of minority interest in subsidiary

  —       —        —    

Excess income tax benefit on employee stock-based awards

  82      —        82   
  

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

  (38,353   —        (38,353

Effect of exchange rate changes on cash

  581      (61   520   
  

 

 

   

 

 

   

 

 

 

Net (decrease) increase in cash and cash equivalents

  (569   (1,274   (1,843

Cash and cash equivalents at the beginning of the year

  31,055      (288   30,767   
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at the end of the year

$ 30,486    $ (1,562 $ 28,924   
  

 

 

   

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

Cash paid during the year for:

Interest

$ 2,046    $ —      $ 2,046   
  

 

 

   

 

 

   

 

 

 

Income taxes

$ 8,773    $ —      $ 8,773   
  

 

 

   

 

 

   

 

 

 

 

The effects of the Original Restatement and the Further Restatement on the Company’s consolidated statement of cash flows for the year ended December 31, 2012 are as follows:

 

(U.S. Dollars, in thousands)

   Year Ended December 31, 2012  
     As Reported in
the 2012 Form
10-K Prior to
Original
Restatement
    Original
Restatement
Adjustments
    As Originally
Restated in
the 2012

Form 10-K/A
    Further
Restatement
Adjustments
    Restated  

Cash flows from operating activities:

          

Net income

   $ 51,295      $ (8,457   $ 42,838      $ 14      $ 42,852   

Adjustments to reconcile net income to net cash provided by operating activities:

          

Depreciation and amortization

     20,261        319        20,580        152        20,732   

Amortization of debt costs

     1,737        —          1,737        —          1,737   

Amortization of exclusivity agreements

     1,289        —          1,289        —          1,289   

Provision for doubtful accounts

     13,302        (2,730     10,572        (8,360     2,212   

Deferred income taxes

     871        (2,123     (1,252     5,023        3,771   

Share-based compensation

     6,303        —          6,303        —          6,303   

Impairment of goodwill

     —          —          —          —          —    

Gain on sale of Breg, Inc, net of tax

     (1,345     —          (1,345     —          (1,345

Excess income tax benefit on employee stock-based awards

     —          (1,020     (1,020     —          (1,020

Income tax benefit on employee-stock-based awards

     —          2,910       2,910        (2,910     —     

Other

     2,125        2,011        4,136        662        4,798   

Changes in operating assets and liabilities, net of effect of dispositions:

          

Trade accounts receivable

     (31,600     13,162        (18,438     7,310        (11,128

Inventories

     (6,341     3,846        (2,495     2,111        (384

Escrow receivable

     41,537        —          41,537        —          41,537   

Prepaid expenses and other current assets

     (6,191     (9,386     (15,577     1,002        (14,575

Trade accounts payable

     5,554        (979     4,575        —          4,575   

Charges related to U.S. Government resolutions

     (82,500     (678     (83,178     —          (83,178

Other current liabilities

     (2,842     (2,887     (5,729     490        (5,239

Other long-term assets

     (2,114     4,241        2,127        (5,518     (3,391

Other long-term liabilities

     (135     751        616        —          616   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

  11,206      (1,020   10,186      (24   10,162   

Cash flows from investing activities:

Capital expenditures for property, plant and equipment

  (27,994   —        (27,994   —        (27,994

Capital expenditures for intangible assets

  (780   —        (780   —        (780

Purchase of other investments

  —        —        —        (714   (714

Proceeds from sale of other investments

  —        —        —        878      878   

Net proceeds from sale of Breg Inc.

  153,773      —       153,773      —       153,773   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

  124,999      —        124,999      164      125,163   

Cash flows from financing activities:

Net proceeds from issuance of common shares

  25,586      —        25,586      —        25,586   

Payment of refinancing fees and debt issuance costs

  —       —        —        —        —    

Repayments of long-term debt

  (188,695   —        (188,695   —        (188,695

Proceeds of bank borrowings, net

  (1,297   —        (1,297   —        (1,297

Changes in restricted cash

  25,799      —        25,799      —        25,799   

Cash payment for purchase of minority interest in subsidiary

  —       —        —        —        —    

Excess income tax benefit on employee stock-based awards

  —       1,020     1,020      —        1,020  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

  (138,607   1,020     (137,587   —        (137,587

Effect of exchange rates changes on cash

  250      —        250      36      286   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

  (2,152   —        (2,152   176      (1,976

Cash and cash equivalents at the beginning of the year

  33,207      —        33,207      (464   32,743   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at the end of the year

$ 31,055    $ —      $ 31,055    $ (288 $ 30,767   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

Cash paid during the year for:

Interest

$ 4,569    $ —      $ 4,569    $ —      $ 4,569   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

$ 18,268    $ —      $ 18,268    $ —      $ 18,268   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

The effects of the Original Restatement and the Further Restatement on the Company’s consolidated statement of cash flows for the year ended December 31, 2011 are as follows:

 

(U.S. Dollars, in thousands)

   Year Ended December 31, 2011  
     As Reported in
the 2012 Form
10-K Prior to
Original
Restatement
    Original
Restatement
Adjustments
    As Originally
Restated in
the 2012

Form 10-K/A
    Further
Restatement
Adjustments
    Restated  

Cash flows from operating activities:

          

Net loss

   $ (1,073   $ (17,037   $ (18,110   $ 412      $ (17,698

Adjustments to reconcile net loss to net cash provided by operating activities:

          

Depreciation and amortization

     22,776        241        23,017        165        23,182   

Amortization of debt costs

     1,239        —         1,239        —          1,239   

Amortization of exclusivity agreements

     374        —          374        —          374   

Provision for doubtful accounts

     11,532        1,404        12,936        (8,356     4,580   

Deferred income taxes

     936        (988     (52     (13,889     (13,941

Share-based compensation

     6,648       —         6,648        —          6,648   

Impairment of goodwill

     —         —         —          —          —    

Gain on sale of Breg, Inc, net of tax

     —         —          —          —          —    

Excess income tax benefit on employee stock-based awards

     (1,737     —         (1,737     —          (1,737

Income tax benefit on employee-stock-based awards

     —         —         —          —          —    

Other

     4,906        (415     4,491        (2,193     2,298  

Changes in operating assets and liabilities, net of effect of dispositions:

          

Trade accounts receivable

     (25,818     26,111        293        6,352        6,645   

Inventories

     (8,349     (4,275     (12,624     (81     (12,705

Escrow receivable

     (32,562     —         (32,562     —          (32,562

Prepaid expenses and other current assets

     (4,057     6,886        2,829        (447     2,382   

Trade accounts payable

     576        1,746        2,322        —          2,322   

Charges related to U.S. Government resolutions

     88,463        638        89,101        —          89,101   

Other current liabilities

     3,384        (1,965     1,419        2,097        3,516   

Other long-term assets

     (1,588     (16,093     (17,681     15,364        (2,317

Other long-term liabilities

     (869     3,747        2,878        525        3,403   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

  64,781      —        64,781      (51   64,730   

Cash flows from investing activities:

Capital expenditures for property, plant and equipment

  (24,965   —        (24,965   —        (24,965

Capital expenditures for intangible assets

  (793   —        (793   —        (793

Payment made in connection with acquisition

  (5,250   —        (5,250   —        (5,250

Purchase of other investments

  —       —           (468 )   (468 )
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) investing activities

  (31,008   —        (31,008   (468   (31,476

Cash flows from financing activities:

Net proceeds from issuance of common shares

  20,113      —        20,113      —        20,113   

Payment of refinancing fees and debt issuance costs

  (758   —        (758   —        (758

Repayments of long-term debt

  (7,500   —        (7,500   —        (7,500

Proceeds of bank borrowings, net

  (2,561   —        (2,561   —        (2,561

Changes in restricted cash

  (24,178   —        (24,178   —        (24,178

Cash payment for purchase of minority interest in subsidiary

  (517   —        (517   —        (517

Excess income tax benefit on employee stock-based awards

  1,737      —        1,737      —        1,737   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

  (13,664   —        (13,664   —        (13,664

Effect of exchange rates changes on cash

  (463   —        (463   55      (408
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) in cash and cash equivalents

  19,646      —        19,646      (464   19,182   

Cash and cash equivalents at the beginning of the year

  13,561      —        13,561      —        13,561   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at the end of the year

$ 33,207    $ —      $ 33,207    $ (464 )   $ 32,743   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

Cash paid during the year for:

Interest

$ 17,088    $ —      $ 17,088    $ —      $ 17,088   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income taxes

$ 26,227    $ —      $ 26,227    $ —      $ 26,227   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

Effects of Original Restatement and Further Restatement on Consolidated Shareholders' Equity

The results of the Further Restatement adjustments to the Company’s previously filed consolidated shareholders’ equity as of January 1, 2011, by category as discussed above under the subheadings “Bad Debt Timing Adjustments”, “Accounts Receivable Reserves”,Intercompany Profit Adjustments”, “Piece Parts Inventory”, “Inventory Reserves” and “Other Adjustments” are summarized in the table below.

 

     Cumulative Adjustments to Shareholders’ Equity at
January 1, 2011
 
     (U.S. Dollars, in thousands)  

Further Restatement Adjustments by Category

Increase (decrease) to Retained earnings

   Further Restatement
Adjustments for
Years ended
December 31, 2009
and Prior
     Further
Restatement
Adjustments to
Year ended
December 31, 2010
     Total Cumulative
Adjustments
through
December 31, 2010
 

Bad debt timing adjustments

   $ —        $ 409       $ 409   

Accounts receivable reserves

     (4,383      (1,037      (5,420

Intercompany profit adjustments

     (812      (203      (1,015

Inventory existence

     (68      (16      (84

Inventory reserves

     (13,352      2,581         (10,771

Other adjustments

     (1,426      (285      (1,711

Income tax benefit (expense)

     7,416         (1,388      6,028   
  

 

 

    

 

 

    

 

 

 

Retained earnings decrease

$ (12,625 $ 61    $ (12,564